Patents Represented by Attorney, Agent or Law Firm Grant Kalinowski
  • Patent number: 8110720
    Abstract: The present invention generally relates to humanized VEGF and non-human transgenic animals expressing it. The transgenic animals are also useful to study VEGF-related therapies.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: February 7, 2012
    Assignee: Genentech, Inc
    Inventor: Napoleone Ferrara
  • Patent number: 7994286
    Abstract: Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: August 9, 2011
    Assignee: Genentech, Inc.
    Inventors: Ryan J. Watts, Yan Wu
  • Patent number: 7803377
    Abstract: The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: September 28, 2010
    Assignee: Genentech, Inc.
    Inventors: Minhong Yan, Yan Wu
  • Patent number: 7482005
    Abstract: The present invention provides monoclonal antibodies, and portions thereof, which are capable of specifically binding to human vascular endothelial cell growth factor (hVEGF) or hVEGF-related protein. The invention also provides hybridoma cell lines that produce such monoclonal antibodies. The monoclonal antibodies of the invention are useful as therapeutic agents, either by themselves or in conjunction with cytotoxic or other chemotherapeutic agents, to treat diseases that are characterized by excessive vascular endothelial cell proliferation. The monoclonal antibodies of the invention also are useful in diagnostic and analytical methods for determining the presence of hVEGF or hVEGF related-protein in a test sample.
    Type: Grant
    Filed: March 5, 2007
    Date of Patent: January 27, 2009
    Assignee: Genentech, Inc.
    Inventor: Kyung Jin Kim
  • Patent number: 7365166
    Abstract: Humanized and variant anti-VEGF antibodies and various uses therefor are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells in vitro; and inhibit tumor growth in vivo.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: April 29, 2008
    Assignee: Genentech, Inc.
    Inventors: Manuel Baca, James A. Wells, Leonard G. Presta, Henry B. Lowman, Yvonne Man-Yee Chen
  • Patent number: 6815581
    Abstract: Nucleic acid molecules are described encoding a starch granule-bound protein as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch with modified viscosity properties and a modified phosphate content. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: November 9, 2004
    Assignee: PlantTec Biotechnologies, GmbH
    Inventors: Jens Kossmann, Ruth Lorberth
  • Patent number: 6762346
    Abstract: Nucleic acid molecules are described, which encode debranching enzymes from maize, as well as transgenic plant cells and plants in which an amylopectin with modified properties is synthesized due to the expression of a debranching enzyme from maize or due to the inhibition of such an endogeneous debranching enzyme activity.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: July 13, 2004
    Assignee: PlantTec Biotechnologie GmbH
    Inventors: Jens Kossmann, Lothar Willmitzer, Michael Emmermann
  • Patent number: 6734339
    Abstract: The present invention relates to nucleic acid molecules encoding enzymes which are involved in the starch synthesis in plants. These enzymes are starch synthases from wheat. The invention further relates to vectors and host cells containing said nucleic acid molecules, in particular transformed plant cells and plants regenerated from these cells, which exhibit an increased or a reduced activity of the described starch synthases.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: May 11, 2004
    Assignee: Hoechst Schering AgrEvo, GmbH
    Inventors: Martina Block, Horst Lörz, Stephanie Lütticke, Lennart Walter, Claus Frohberg, Jens Kossmann
  • Patent number: 6716612
    Abstract: The invention describes DNA molecules which code for plant proteins having the biological activity of a debranching enzyme. Furthermore described are transgenic plant cells and plants having reduced or increased debranching enzyme activity, as well as modified starch isolatable from the cells and plants.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: April 6, 2004
    Inventors: Jens Kossmann, Michael Emmermann, Ivar Virgin, Andreas Renz
  • Patent number: 6686514
    Abstract: Nucleic acid molecules are described which encode enzymes involved in the starch synthesis in plants. These enzymes are starch phosphorylases from maize. The invention further relates to vectors containing such nucleic acid molecules and to host cells transformed with the described nucleic acid molecules, in particular to transformed plant cells and to plants which may be regenerated therefrom and which exhibit an increased or reduced activity of the described proteins.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: February 3, 2004
    Assignee: PlantTec Biotechnologie GmbH Forshung & Entwicklung
    Inventors: Jens Kossmann, Claus Frohberg
  • Patent number: 6670525
    Abstract: Nucleic acid molecules are described, which encode debranching enzymes from potato, as well as transgenic plant cells and plants in which an amylopectin with modified properties is synthesized due to the expression of a debranching enzyme from potato or due to the inhibition of such an endogeneous debranching enzyme activity.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: December 30, 2003
    Assignee: PlantTec Biotechnologie GmbH
    Inventors: Michael Emmermann, Jens Kossmann
  • Patent number: 6635454
    Abstract: The invention describes DNA molecules which code for plant proteins having the biological activity of a debranching enzyme. Furthermore described are transgenic plant cells and plants having reduced or increased debranching enzyme activity, as well as modified starch isolatable from the cells and plants.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: October 21, 2003
    Inventors: Jens Kossmann, Michael Emmermann, Ivar Virgin, Andreas Renz
  • Patent number: 6635804
    Abstract: Nucleic acid molecules are described encoding enzymes involved in the starch synthesis in plants. These enzymes are a novel isotype of soluble starch synthases from maize. Furthermore, the invention relates to vectors containing such nucleic acid molecules and to host cells, which have been transformed with said nucleic acid molecules, in particular to transformed plant cells or plants regenerable therefrom, which exhibit an increased or reduced activity of the described proteins.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: October 21, 2003
    Assignee: PlantTec Biotechnologie, GmbH
    Inventors: Jens Kossmann, Claus Frohberg
  • Patent number: 6617495
    Abstract: Nucleic acid molecules encoding enzymes which participate in the starch synthesis in plants are described. These enzymes are a novel isotype of starch synthase. Furthermore, the invention relates to vectors and hose cells which were transformed with the described nucleic acid molecules, in particular to transformed plant cells and to plants which may be regenerated therefrom and which exhibit an increased or reduced activity of the described proteins.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: September 9, 2003
    Assignee: PlantTec Biotechnologie GmbH
    Inventors: Jens Kossmann, Claus Frohberg
  • Patent number: 6610843
    Abstract: The present invention describes transgenic plant cells and plants which due to a reduced activity of a disproportionating enzyme (D enzyme) synthesize a modified starch. Furthermore, the starch synthesized in these plant cells and plants is described.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: August 26, 2003
    Assignee: Bayer CropScience GmbH
    Inventors: Jens Kossmann, Franziska Springer, Volker Büttcher
  • Patent number: 6521816
    Abstract: Nucleic acid molecules are described encoding a starch granule-bound protein from rice as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: February 18, 2003
    Assignee: PlantTec Biotechnologie GmbH Forschung und Entwicklung
    Inventor: Claus Frohberg
  • Patent number: 6483010
    Abstract: The present invention relates to DNA molecules encoding enzymes which are involved in the starch synthesis of plants. These enzymes represent two different isotypes of the soluble starch synthase as well as a starch granule-bound starch synthase. This invention furthermore relates to vectors, bacteria, as well as to plant cells transformed with the DNA molecules described and to plants regenerated from them. Furthermore, the invention relates to starch that can be isolated from plants having an increased or reduced activity of the proteins described.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: November 19, 2002
    Inventors: Jens Kossmann, Franziska Springer, Gernot J. Abel
  • Patent number: 6483012
    Abstract: Described is the use of the promoter region of the DefH9 gene of Anthirrhinum majus or of a promoter of a homologous gene displaying the same expression pattern and characteristics for the establishment of parthenocarpy or female sterility in plants, for increasing gynogenesis or for enhancing fruit setting and development. Also described are recombinant DNA molecules comprising a DefH9 promoter in combination with a DNA sequence which upon expression in plants leads to the above mentioned effects. Furthermore, described are plant cells and plants transformed with such recombinant DNA molecules.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: November 19, 2002
    Assignee: Max-Planck-Gesellschaft zur Förederung der Wissenschaften e.V.
    Inventors: Angelo Spena, Heinz Saedler, Hans Sommer, Guiseppe Leonardo Rotino
  • Patent number: 6353154
    Abstract: Nucleic acid molecules are described which encode enzymes involved in the starch synthesis in plants. These enzymes are starch phosphorylases from maize. The invention further relates to vectors containing such nucleic acid molecules and to host cells transformed with the described nucleic acid molecules, in particular to transformed plant cells and to plants which may be regenerated therefrom and which exhibit an increased or reduced activity of the described proteins.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: March 5, 2002
    Assignee: PlantTec Biotechnologie GmbH Forschung & Entwicklung
    Inventors: Jens Kossmann, Claus Frohberg